PCOS and Weight Gain: Why It Happens and What Helps

The short answer

Weight gain from polycystic ovary syndrome is driven largely by insulin resistance, not willpower: the body over-produces insulin, which promotes fat storage and makes weight hard to lose. [4] After menopause this often gets harder, because the insulin resistance and metabolic effects of the condition persist and stack on top of menopausal body-composition change. [3] The 2023 international guideline puts healthy lifestyle first, with metformin and, increasingly, glucagon-like peptide-1 (GLP-1) medicines for weight and metabolic management. [1] Because the condition raises the risk of type 2 diabetes and heart disease with age, glucose and cardiovascular screening matter. [1] [4]

What you’ll learn

Weight gain with the condition is largely metabolic: insulin resistance drives fat storage and makes weight loss harder, so it is not simply a willpower problem. [4]
It often worsens after menopause, because the condition's insulin resistance persists and adds to menopausal body-composition change. [3]
The 2023 international guideline puts healthy lifestyle first, then metformin and increasingly GLP-1-type medicines for weight and metabolic risk. [1]
PCOS (recently renamed PMOS, polyendocrine metabolic ovarian syndrome) raises the risk of type 2 diabetes and cardiovascular disease as women age. [2] [4]
Glucose, blood pressure, and cholesterol screening matter more with the condition, especially after 40. [1] [4]

If weight has crept up with the condition despite doing "everything right," the problem is usually not willpower. It is metabolism.

Polycystic ovary syndrome is largely a metabolic condition: insulin resistance leads the body to over-produce insulin, which promotes fat storage and makes weight loss harder. [4] The name itself was recently changed to reflect this: in 2026 the condition was formally renamed polyendocrine metabolic ovarian syndrome (PMOS), because "PCOS" had reduced a complex hormonal and metabolic disorder to a misunderstanding about cysts. [2]

The gap worth naming is between "eat less, move more" advice and the biology actually driving the scale, which matters even more after 40.

Why insulin resistance drives the weight

In the condition, the body does not use insulin well, so it makes more of it. That extra insulin encourages fat storage and can make it genuinely harder to lose weight, and it links the condition to prediabetes and type 2 diabetes. [4] This is why weight change with the condition behaves differently than a simple calorie story.

Why it often gets harder after menopause

The condition does not disappear at menopause. Ovulation and periods stop, but the insulin resistance, higher androgens, and metabolic effects usually stick around, and they stack on top of the body-composition changes menopause brings, a combination one review described as a double hit. [3] The risk of high blood pressure, high cholesterol, and cardiovascular disease rises significantly in this stage. [3]

What the evidence says helps

What the evidence says helps
Approach	What it is	Evidence
Healthy lifestyle	Nutrition, activity, sleep, well-being	First-line in the 2023 international guideline [1]
Metformin	Insulin-sensitizing medicine	Recommended for metabolic features and weight [1] [4]
GLP-1-type medicines	Anti-obesity medicines	Increasingly included for weight management in the 2023 guideline [1]
Metabolic screening	Glucose (A1c or oral glucose tolerance test), lipids, blood pressure	Recommended because diabetes and heart risk rise with age [1] [4]

The honest limit is that the evidence is limited for any single medication as a stand-alone fix, and no approach removes the underlying metabolic drive, so results are usually gradual and best sustained with a clinician-guided plan.

The screening that matters after 40

Because the condition raises the risk of type 2 diabetes and cardiovascular disease as women age, the guideline emphasizes screening: glucose with an A1c or oral glucose tolerance test, plus blood pressure and cholesterol. [1] [4] For deeper detail, see diabetes screening after menopause and insulin resistance after menopause.

Who this fits

This fits women with the condition whose weight has become harder to manage and who want a metabolic, clinician-guided approach rather than another restrictive diet. It is not a fit for treating rapid, unexplained weight change or new symptoms as "just the condition": sudden weight gain with swelling or shortness of breath, or any bleeding after menopause, is a warning sign that should be checked promptly rather than assumed. [3]

What to ask your clinician

Is my weight change being driven by insulin resistance, and should we check glucose, lipids, and blood pressure?
Would metformin or a GLP-1-type medicine fit my situation alongside lifestyle changes?
How do we set realistic, sustainable goals rather than chasing rapid loss?
What symptoms would mean a weight change should be evaluated rather than managed as the condition?

Bottom line

Weight gain with the condition is mainly metabolic, driven by insulin resistance, and it often becomes harder after menopause as those effects persist. [3] [4] The evidence-based plan starts with lifestyle and adds metformin or GLP-1-type medicines when appropriate, alongside glucose, blood pressure, and cholesterol screening because diabetes and heart risk rise with age. [1] It is a clinician-guided, metabolic problem, not a willpower test, and lasting progress comes from treating the metabolism rather than fighting the scale alone.

References

[1] Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Eur J Endocrinol. 2023;189(2):G43-G64. doi:10.1093/ejendo/lvad096 https://pubmed.ncbi.nlm.nih.gov/37580861/

[2] American Society for Reproductive Medicine. PCOS is now PMOS: understanding the name change. 2026. https://www.asrm.org/news-and-events/asrm-news/latest-news/may-27-2026-pcos-is-now-pmos-understanding-the-name-change/

[3] Harvard Health Publishing. How PMOS (once called PCOS) affects women after menopause. 2026. https://www.health.harvard.edu/womens-health/how-pmos-once-called-pcos-affects-women-after-menopause

[4] MedlinePlus. Polycystic ovary syndrome. U.S. National Library of Medicine. https://medlineplus.gov/polycysticovarysyndrome.html

Common questions

Why does PCOS cause weight gain?

Mainly insulin resistance: the body makes extra insulin, which promotes fat storage and makes weight harder to lose. It is a metabolic driver, not a willpower failure. [4][4]

Does PCOS weight gain get worse after menopause?

Often, yes. The insulin resistance and metabolic effects of the condition persist after menopause and add to menopausal body-composition change, a kind of double hit. [3][3]

What helps with PCOS weight gain?

The 2023 international guideline puts healthy lifestyle first, with metformin and, increasingly, GLP-1-type medicines for weight and metabolic management, guided by a clinician. [1][1]

What screening should I have with PCOS after 40?

Because the condition raises the risk of type 2 diabetes and heart disease with age, clinicians screen glucose with an A1c (hemoglobin A1c) test or an oral glucose tolerance test, plus blood pressure and cholesterol. [1] [4][1][4]